Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)

Corinna Engel,Mario Rüdiger,Manon J. N. L. Benders,Frank van Bel,Karel Allegaert,Gunnar Naulaers,Dirk Bassler,Katrin Klebermaß-Schrehof,Maximo Vento,Ana Vilan,Mari Falck,Isabella Mauro,Marjo Metsäranta,Sampsa Vanhatalo,Jan Mazela,Tuuli Metsvaht,Roselinda van der Vlught,Axel R. Franz,Christian F. Poets,Hercilia Guimarães,Tom Stiri,Luigi Cattarossi,Cees K. W. van Veldhuizen,Christian A. Maiwald,Iris Bergmann,Monika Weiss,Andreas Eichhorn,Michael Raubuch,Birgit Schuler,Bas Laméris,Thirza van Ramshorst,Tirol Kliniken,Johannes Brandner,Marie Tackoen,Ruth Reibel,Mari-Liis Ilmoja,Pille Saik,Ruth Käär,Pille Andresson,Klinikum der J. W. Goethe,Main Rolf Schloesser,Carl Gustav Carus,Stefan Winkler,Thomas Hoehn,Norbert Teig,Michael Schroth,Christoph Fusch,Ulrich H. Thome,Harald Ehrhardt,Ancona Virgilio Carnielli,Marcello Napolitano,Francesca Faldini,Bambini “V.Buzzi”,Milano Gianluca Lista,Mario Barbarini,Laura Pagani,Emmanuele Mastretta,Giovanni Vento,Monica Fumagalli,Mirjam M. van Weissenbruch,Henrica L. M. van Straaten,Kim V. Annink,Jeroen Dudink,Jan B. Derks,Inge P. de Boer,Clemens B. Meijssen,Timo R. de Haan,Linda G. van Rooij,Jacqueline L. van Hillegersberg,Minouche van Dongen,Koen P. Dijkman,Marlies A. van Houten,Sophie R. D. van der Schoor,Moritz Schneider,Eirik Nestaas,Britt Nakstad,Lukas Karpinski,Ewa Gulczynska,Claudia Ferraz,Almerinda Pereira,Rosalina Barroso,Mendes da Graça,Teresa Tomé,Filomena Pinto,Juan Martínez Rodilla,Maria Luz.Couce Pico,José Antonio Hurtado Suazo,Eva Valverde,José Ramón Fernández Lorenzo,Héctor Boix,Francisco Jimenez Parrilla,Dorotea Blanco,Begoña Loureiro,Maria Teresa Moral-Pumarega,Julia Maletzki,Claudia Knoepfli,Cornelia Hagmann,Michael Kleber,Martin Stocker,Thomas Riedel,for the ALBINO Study Group
DOI: https://doi.org/10.1186/s13063-023-07828-6
IF: 2.728
2024-01-25
Trials
Abstract:Despite therapeutic hypothermia (TH) and neonatal intensive care, 45–50% of children affected by moderate-to-severe neonatal hypoxic-ischemic encephalopathy (HIE) die or suffer from long-term neurodevelopmental impairment. Additional neuroprotective therapies are sought, besides TH, to further improve the outcome of affected infants.
medicine, research & experimental
What problem does this paper attempt to address?